Acute Imidacloprid Poisoning in Thailand
Charuwan Sriapha,1 Satariya Trakulsrichai,1,2 Achara Tongpoo,1 Aimon Pradoo,1 Panee Rittilert,1 Winai Wananukul1,3 1Ramathibodi Poison Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand; 2Department of Emergency Medicine, Faculty of Medicine Ramathibodi Hos...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/52487ff975e541a59d3067662aacd6e8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:52487ff975e541a59d3067662aacd6e8 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:52487ff975e541a59d3067662aacd6e82021-12-02T12:46:32ZAcute Imidacloprid Poisoning in Thailand1178-203Xhttps://doaj.org/article/52487ff975e541a59d3067662aacd6e82020-11-01T00:00:00Zhttps://www.dovepress.com/acute-imidacloprid-poisoning-in-thailand-peer-reviewed-article-TCRMhttps://doaj.org/toc/1178-203XCharuwan Sriapha,1 Satariya Trakulsrichai,1,2 Achara Tongpoo,1 Aimon Pradoo,1 Panee Rittilert,1 Winai Wananukul1,3 1Ramathibodi Poison Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand; 2Department of Emergency Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 1400, Thailand; 3Division of Clinical Pharmacology and Toxicology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 1400, ThailandCorrespondence: Satariya TrakulsrichaiRamathibodi Poison Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, ThailandTel +66-2-2011084Fax +66-2-2011086Email satariya.tra@mahidol.ac.thIntroduction: Imidacloprid is the most commonly used neonicotinoid insecticide worldwide. Despite its reputation for safety, there is increasing evidence regarding its toxicity. This study characterized the clinical manifestations and outcomes of acute imidacloprid poisoning.Methods: This was a retrospective study of patients with imidacloprid poisoning who were referred to the Ramathibodi Poison Center in Bangkok, Thailand between 2010 and 2018.Results: A total of 163 patients with imidacloprid-only exposure were included. Most were exposed by ingestion (93.3%). The patients were predominantly male (55.8%), with a median age of 41.3 years. The common presenting features were gastrointestinal symptoms (63.8%) with no corrosive injuries and neurological effects (14.2%). The majority of medical outcomes was no (18.4%) to mild (76.1%) toxicity. One patient had symptoms mimicking cholinergic syndrome, three developed liver injury, and five died. Among the five deaths, two patients presented severe initial severity, and one presented moderate initial severity. Two of the patients who died initially presented only mild severity. The mortality rate was 3.1%. The estimated amount of ingestion, cardiovascular effects (especially tachycardia and cardiac arrest), central nervous system effects (especially coma), dyspnea, and diaphoresis were significantly associated with mortality. Patient management primarily included supportive and symptomatic care.Conclusion: Most patients with imidacloprid poisoning developed only mild toxicity. The mortality rate was low, but a few patients with mild initial severity died. Patients who ingest a large amount or show these warning signs including cardiovascular effects, central nervous system effects, dyspnea, and diaphoresis at the initial presentation should be considered for close observation and monitoring.Keywords: imidacloprid, neonicotinoid insecticide, poisoning, toxicity, humansSriapha CTrakulsrichai STongpoo APradoo ARittilert PWananukul WDove Medical Pressarticleimidaclopridneonicotinoid insecticidepoisoningtoxicityhumansTherapeutics. PharmacologyRM1-950ENTherapeutics and Clinical Risk Management, Vol Volume 16, Pp 1081-1088 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
imidacloprid neonicotinoid insecticide poisoning toxicity humans Therapeutics. Pharmacology RM1-950 |
spellingShingle |
imidacloprid neonicotinoid insecticide poisoning toxicity humans Therapeutics. Pharmacology RM1-950 Sriapha C Trakulsrichai S Tongpoo A Pradoo A Rittilert P Wananukul W Acute Imidacloprid Poisoning in Thailand |
description |
Charuwan Sriapha,1 Satariya Trakulsrichai,1,2 Achara Tongpoo,1 Aimon Pradoo,1 Panee Rittilert,1 Winai Wananukul1,3 1Ramathibodi Poison Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand; 2Department of Emergency Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 1400, Thailand; 3Division of Clinical Pharmacology and Toxicology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 1400, ThailandCorrespondence: Satariya TrakulsrichaiRamathibodi Poison Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, ThailandTel +66-2-2011084Fax +66-2-2011086Email satariya.tra@mahidol.ac.thIntroduction: Imidacloprid is the most commonly used neonicotinoid insecticide worldwide. Despite its reputation for safety, there is increasing evidence regarding its toxicity. This study characterized the clinical manifestations and outcomes of acute imidacloprid poisoning.Methods: This was a retrospective study of patients with imidacloprid poisoning who were referred to the Ramathibodi Poison Center in Bangkok, Thailand between 2010 and 2018.Results: A total of 163 patients with imidacloprid-only exposure were included. Most were exposed by ingestion (93.3%). The patients were predominantly male (55.8%), with a median age of 41.3 years. The common presenting features were gastrointestinal symptoms (63.8%) with no corrosive injuries and neurological effects (14.2%). The majority of medical outcomes was no (18.4%) to mild (76.1%) toxicity. One patient had symptoms mimicking cholinergic syndrome, three developed liver injury, and five died. Among the five deaths, two patients presented severe initial severity, and one presented moderate initial severity. Two of the patients who died initially presented only mild severity. The mortality rate was 3.1%. The estimated amount of ingestion, cardiovascular effects (especially tachycardia and cardiac arrest), central nervous system effects (especially coma), dyspnea, and diaphoresis were significantly associated with mortality. Patient management primarily included supportive and symptomatic care.Conclusion: Most patients with imidacloprid poisoning developed only mild toxicity. The mortality rate was low, but a few patients with mild initial severity died. Patients who ingest a large amount or show these warning signs including cardiovascular effects, central nervous system effects, dyspnea, and diaphoresis at the initial presentation should be considered for close observation and monitoring.Keywords: imidacloprid, neonicotinoid insecticide, poisoning, toxicity, humans |
format |
article |
author |
Sriapha C Trakulsrichai S Tongpoo A Pradoo A Rittilert P Wananukul W |
author_facet |
Sriapha C Trakulsrichai S Tongpoo A Pradoo A Rittilert P Wananukul W |
author_sort |
Sriapha C |
title |
Acute Imidacloprid Poisoning in Thailand |
title_short |
Acute Imidacloprid Poisoning in Thailand |
title_full |
Acute Imidacloprid Poisoning in Thailand |
title_fullStr |
Acute Imidacloprid Poisoning in Thailand |
title_full_unstemmed |
Acute Imidacloprid Poisoning in Thailand |
title_sort |
acute imidacloprid poisoning in thailand |
publisher |
Dove Medical Press |
publishDate |
2020 |
url |
https://doaj.org/article/52487ff975e541a59d3067662aacd6e8 |
work_keys_str_mv |
AT sriaphac acuteimidaclopridpoisoninginthailand AT trakulsrichais acuteimidaclopridpoisoninginthailand AT tongpooa acuteimidaclopridpoisoninginthailand AT pradooa acuteimidaclopridpoisoninginthailand AT rittilertp acuteimidaclopridpoisoninginthailand AT wananukulw acuteimidaclopridpoisoninginthailand |
_version_ |
1718393685568126976 |